MMCB2019

Defective innate and adaptive immunity in mutant mice carrying a novel heterozygous missense mutation of a proteasome subunit, PSMB9, in a patient with autoinflammation and immunodeficiency

Tsuneyasu Kaisho

Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University

Mechanisms controlling innate immune responses to nucleic acids

Kensuke Miyake

Div. Innate Immunity, Inst Med Sci, Univ. Tokyo

Cytosolic RNA sensing and inflammation

Sun Hur

Harvard Medical School

Tissue-Resident Innate Immune Responses during Obesity

Timothy E. O’Sullivan

Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at UCLA

Reciprocal interaction between blood vessels and immune cells in CNS development

Yoshiaki Kubota

Department of Anatomy, Keio University School of Medicine

Anti-diabetes drug, metformin, drives metabolic reprogramming in tumor microenvironment, leading to manifestation of anti-tumor immunity

Heiichiro Udono

Department of Immunology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

Development of therapeutic cancer vaccine utilizing invariant NKT cell-licensed dendritic cells

Shin-ichiro Fujii

Leader of Laboratory for Immunotherapy, RIKEN IMS
Vice director of RIKEN DMP (Drug discovery and medical technology platforms)
Visiting professor, Chiba University

Nuclear cytokines and extracellular nucleic acids in infection and vaccination

Ken J. Ishii

Division of Vaccine Science, Institute of Medical Science, The University of Tokyo

Dendritic cells as a checkpoint in anti-cancer immunity

Caetano Reis e Sousa

Immunobiology Laboratory, The Francis Crick Institute

Stem cells, Cancer Stem Cells, and Macrophage Checkpoint Inhibition as Cancer Immunotherapy

Irving Weissman

Stanford University

Regnase-1: A Key regulator of the mRNA stabilization during interleukin-17-induced inflammation

Hiroki Tanaka

Immunology Frontier Research Center (IFReC), Osaka University

The roles and mechanisms of cellular senescence in aging and cancer

Eiji Hara

Department of Molecular Microbiology, Research Institute for Microbial Diseases, Osaka University

Role of group 2 innate lymphoid cells in idiopathic interstitial pneumonias

Kazuyo Moro

Laboratory for Innate Immune Systems, Graduate School of Medicine, Osaka University, Laboratory for Innate Immune Systems, RIKEN-IMS

Systems approach to target discovery for vascular disease: a focus on macrophage activation and heterogeneity

Masanori Aikawa

Harvard Medical School/Center for Interdisciplinary Cardiovascular Sciences/Center for Excellence in Vascular Biology, Department of Medicine, Brigham and Women's Hospital

Probing the IL10 axis in Macrophages in Gut and Brain

Steffen Jung

University of Cologne, Germany / The Hebrew University, Jerusalem, Israel/ Skirball Institute, NYU Medical Center, NY, USA

Macrophages in cardiac physiology and disease

Ichiro Manabe

Department of Disease Biology and Molecular Medicine, Graduate School of Medicine, Chiba University

Regulation of Inflammasome Responses

Eicke Latz

Institute of Innate Immunity, University of Bonn Medical Center, Sigmund-Freud Str. 25, D-53105 Bonn, Germany

Immunity, trade-offs and disease tolerance

Ajay Chawla

Cardiovascular Research Institute, University of California, San Francisco

Coordinated regulation of inflammatory response and lipid metabolism in macrophages

Yumiko Oishi

Department of Biochemistry and Molecular Biology, Nippon Medical School

Semaphorin 6D reverse signaling controls macrophage polarizations, coupling immune and metabolic systems

Atsushi Kumanogoh

Department of Respiratory Medicine and Clinical Immunology, Osaka University, Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka, 565-0871, Japan.